January 22, 2020
CooperVision introduced the Brilliant Futures Myopia Management Program to create a new standard of care for children with myopia, as the company prepares to launch its…
January 22, 2020
The first patient has been enrolled in a phase 3 trial of Aldeyra Therapeutics’ allergic conjunctivitis treatment candidate reproxalap, according to a press…
Blog
January 21, 2020
The hot topic of discussion in health care reform this winter revolves around patient access to their medical information. One of the founding tenets of patient-centered…
January 21, 2020
The FDA has approved a facility in Athlone, Ireland, for production of Rocklatan for the U.S. market, Aerie Pharmaceuticals announced in a press release. Rocklatan…